PENGARUH NEBULIZER, INFRARED DAN TERAPI LATIHAN PADA PENYAKIT PARU OBSTRUKTIF KRONIK (PPOK) ET CAUSA ASMA BRONKIAL
NEBULIZER, INFRARED AND EXERCISE THERAPY EFFECT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ET CAUSA ASMA BRONCHIALE
Abstract
Latar Belakang : Penyakit Paru Obstruktif Kronik (PPOK) di Kota Semarang prevalensi tahun 2011 sekitar 4249 kasus, tahun 2012 sekitar 1342 kasus, tahun 2013 sekitar 820 kasus, dan tahun 2014 sekitar kasus, berdasarkan kematian kasus Penyakit Paru Obstruktif di Kota Semarang prevalensi dari tahun 2010 sekitar 36 orang, pada tahun 2011 sekitar 36 orang, tahun 2012 sekitar 66 orang, tahun 2013 sekitar 81 orang, dan tahun 2014 sekitar 54 orang. Penelitian ini dilakukan di RSUD KRMT Wongsonegoro pada bulan Mei 2017 dengan mengambil sampel sebanyak 8 orang partisipan sedangkan metode quasi eksperimen jenis pretest-posttest. Intervensi yang diberikan berupa infrared, nebulizer dan terapi latihan.
Tujuan : Menegetahui pengaruh penggunaan infrared, nebulizer dan terapi latihan pada kasus PPOK et causa asma Bronkial.
Hasil : Uji normalitas dengan saphiro wilk test nilai sig. respiratory rate sebelum dilakukan terapi 0.634, nilai sig. respiratory rate sesudah dilakukan terapi 0.139, nilai sig. Skala Borg sebelum dilakukan terapi 0.522 dan Skala Borg sesudah dilakukan terapi 0.098 maka nilai sig. > 0,05 Hal ini berarti distribusi data normal. Uji hipotesis pada penelitian ini menggunakan paired sample t test dengan hasil sig 2 tailed untuk respiratory rate 0,007 sedangkan nilai sig skala Borg 2 tailed sebesar 0,001. Maka nilai sig 2 tailed <0,05. Hal ini berarti terjadi perubahan yang signifikan pada partisipan setelah diberikan terapi.
Kesimpulan : intervensi yang diberikan berupa penggunaan infrared, nebulizer dan terapi latihan. Terbukti efektif dalam memperbaiki respiratory rate dan mengurangi sesak napas pada kasus PPOK et causa asma bronkial.
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
The use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution 4.0 International License.
Author’s Warranties
The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
User Rights
JFR's spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, JFR permits users to copy, distribute, display, and perform the work. Users will also need to attribute authors and JFR on distributing works in the journal.
Rights of Authors
Authors retain all their rights to the published works, such as (but not limited to) the following rights;
- Copyright and other proprietary rights relating to the article, such as patent rights,
- The right to use the substance of the article in own future works, including lectures and books,
- The right to reproduce the article for own purposes,
- The right to self-archive the article
Co-Authorship
If the article was jointly prepared by other authors, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. JFR will not be held liable for anything that may arise due to the author(s) internal dispute. JFR will only communicate with the corresponding author.
Miscellaneous
JFR will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. JFR's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.